Noticias de BCRX_US

Noticias del mercado

Últimas noticias sobre BCRX_US — 83 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: BCRX_US ✕ 83 resultados
20/03/2026 BCRX_US — MSN
BioCryst (BCRX) rallies 7.10% on acquisition buzz
20/03/2026 BCRX_US — Yahoo Finance
BioCryst (BCRX) Rallies 7.10% on Acquisition Buzz
20/03/2026 BCRX_US — Stock Titan
[144] BIOCRYST PHARMACEUTICALS INC SEC Filing
19/03/2026 BCRX_US — Yahoo Finance
BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now?
18/03/2026 BCRX_US — Smartkarma
BioCryst Pharmaceuticals: Why This $2B Drugmaker Is Suddenly On Big Pharma’s Radar!
18/03/2026 BCRX_US — Stock Titan
BioCryst (BCRX) CLO sells 150K shares after option exercise
18/03/2026 BCRX_US — Investing.com
BioCryst (BCRX) chief legal officer Barnes sells $1.37m in shares
17/03/2026 BCRX_US — Seeking Alpha
BioCryst: The Buyout Rumor Is Noise, The Franchise Is Real (NASDAQ:BCRX)
17/03/2026 BCRX_US — MSN
BioCryst (BCRX) soars 13% on acquisition buzz
16/03/2026 BCRX_US — MSN
BioCryst gains amid takeover speculation
16/03/2026 BCRX_US — MSN
BioCryst gains amid takeover speculation
16/03/2026 BCRX_US — Stock Titan
Form 144 resale notice lists 150,000 shares (NASDAQ: BCRX)
16/03/2026 BCRX_US — MarketBeat
BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price Up 13.8% - Here's What Happened
16/03/2026 BCRX_US — Yahoo Finance
BioCryst (BCRX) Soars 13% on Acquisition Buzz
16/03/2026 BCRX_US — GuruFocus ES ← EN
BioCryst Pharmaceuticals (BCRX) aumenta un 15% en medio de especulaciones de adquisiciones
16/03/2026 BCRX_US — timothysykes.com ES ← EN
Las acciones de BioCryst aumentan después de las sólidas ganancias del cuarto trimestre y la adquisición de Astria
16/03/2026 BCRX_US — StocksToTrade
BioCryst Pharmaceuticals Sees Profitable Quarter Amid Strategic Moves
10/03/2026 BCRX_US — Yahoo Finance
BioCryst Pharma (BCRX) Subject to Prise Target Raise by Wedbush
06/03/2026 BCRX_US — MSN
Jim Cramer on BioCryst Pharmaceuticals: "Just stay away from that"
03/03/2026 BCRX_US — Stock Titan
Biocryst (NASDAQ: BCRX) director executes option exercise and share disposition

Página 3 de 5

keyboard_arrow_up